Description: Humanwell Healthcare (Group) Co.,Ltd. provides healthcare solutions in the Asia Pacific, North America, Africa, and internationally. The company offers anesthetic/analgesic products; women's health products for unplanned pregnancy, emergency contraception, and birth control; consumer healthcare products for women; and CNS drugs for bronchitis, migraine, dysmenorrhea, neuralgia, epilepsy, acute and chronic cerebrovascular diseases, and brain injury and peripheral vascular diseases. It also provides herbal medicines for cold and flu, rheumatoid arthritis, skin care, hepatitis, urinary tract infection, and hypomnesis; anti-infection drugs; OTC medicines for digestive disorders, cold and flu, anti-inflammation, anti-infection, and nutritional supplements; and other products targeting cardiovascular, gastrointestinal, and reproductive diseases. The company was formerly known as Wuhan Humanwell Healthcare (Group) Co., Ltd. and changed its name to Humanwell Healthcare (Group) Co.,Ltd. in March 2013. Humanwell Healthcare (Group) Co.,Ltd. was founded in 1993 and is based in Wuhan, China.
Home Page: www.humanwell.com.cn
No.666 Gaoxin Road
Wuhan,
430075
China
Phone:
86 27 8717 3710
Officers
| Name | Title |
|---|---|
| Mr. Xiafei Deng | Pres & Director |
| Ms. Yajun Wu | CFO & VP |
| Mr. Wentao Du | VP |
| Ms. Lie Li | VP |
| Mr. Hongjie Zhang | VP |
| Mr. Qiang Yin | VP |
| Mr. Qun Yu | VP |
| Mr. Qianlun Li | VP & Sec. |
Exchange: SHG
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 17.1974 |
| Price-to-Book MRQ: | 2.5183 |
| Price-to-Sales TTM: | 1.7416 |
| IPO Date: | 1997-05-22 |
| Fiscal Year End: | December |
| Full Time Employees: | 15746 |